About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, January 12th, 2016

The QualityStocks
Daily Stock List


Major League Football, Inc. (MLFB)

TopPennyStockMovers, Stock News Now, and SmallCapVoice reported earlier on Major League Football, Inc. (MLFB), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.

Major League Football, Inc. is a new, professional spring-football league scheduled to start this year. The Company’s shares commenced trading on the OTC Markets Group’s OTCQB on September 16, 2015. The Company previously went by the name Universal Capital Management, Inc. It changed its name to Major League Football, Inc. in November of 2014. The Company’s plan is to establish franchises and provide fans with professional football in the National Football League off-seasons. Major League Football is headquartered in Lakewood Ranch, Florida.

The Company’s dedication is to creating a ground-breaking, accessible, and fan-owned game. The teams of the league will focus on emerging markets in select U.S. cities to grow the overall popularity of the sport. Major League Football is considering in excess of 14 new markets as potential cities the league will further review to set the number of teams in its inaugural season.

Football games will be played from early April and continue through June. For the planned second season in 2017, additional cities will be considered for expansion.

In September 2015, Major League Football announced that it began finalizing potential host venues across the country to establish cities that will become the inaugural season team sites. The Company is confirming its plans based on the earlier round of financing acquired by the league and additional investor interest.

Major League Football said that it will review the venues in cities earlier announced, evaluate fan appeal, local business support and other criteria. This is to reconfirm cities and their venues best suited for the league's inaugural kick off, which is planned for this year.

Today, Major League Football announced a two-year television contract with American Sports Network (ASN). ASN is a division of Sinclair Networks Group, owned by Sinclair Broadcast Group (SBGI). The deal includes broadcasting all regular season and post season games in 2016 and 2017 for Major League Football's new professional spring football league.

Major League Football, Inc. (MLFB), closed Tuesday's trading session at $0.81, up 1.25%, on 52,979 volume with 44 trades. The average volume for the last 60 days is 17,027 and the stock's 52-week low/high is $0.1405/$1.72.

Steampunk Wizards, Inc. (SPWZ)

Financials Trend reported recently on Steampunk Wizards, Inc. (SPWZ), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.

Steampunk Wizards, Inc. is a Games Development Company based in Los Angeles, California. An independent games development and technology business, Steampunk Wizards specializes in developing captivating games and gaming technology where the real and virtual worlds blur. The Company is now concentrating on releasing new games and also further expansion. Steampunk Wizards’ shares trade on the OTCQB.

Steampunk Wizards incorporated in 2014 to acquire the Intellectual Property (IP) related to an unfinished game entitled “Tangled Tut”. The Company acquired Steampunk Wizards Ltd. in July 2015. It announced that on Friday, August 21, 2015, it closed the acquisition by Steampunk Wizards, Inc. of Steampunk Wizards Ltd. This was pursuant to the completion of an audit of the Maltese subsidiary by U.S. auditors, which has been done to PCAOB standards.

Steampunk Wizards has an in-house team of designers, developers, artists, programmers and marketers, which enable it to design and develop its own games through every stage - from conception to publication. It built the first mobile game with 3D printable rewards embedded, and the associated IP and server technology.

The Company provides 3D printable codes as in-game rewards. These permit gamers to print off merchandise they have earned through gameplay. The Company’s initial game is Bungee Mummy. This is a level-based adventure-puzzler with an Egyptian theme. It is a mobile game and the design of it is mainly for smartphones and tablets, supporting Android and IOS.

Steampunk owns the Bungee Mummy game franchise and has released three games, Bungee Mummy: Reborn and Bungee Mummy: Challenges, both from the Bungee Mummy franchise, and a new game, Whack a Geemie, an offshoot from the franchise using some of the most popular characters.

Its Bungee Mummy: Challenges is a free-to-play collection of casual mini-games on Steampunk’s Bungee Mummy game theme.  Its Whack a Geemie uses characters from the Bungee Mummy franchise in a whack-a-mole style game. Players must first watch a reel of spinning Geemie characters come to a stop. They subsequently need to hit as many of that kind of Geemie as possible, without hitting any of the others.

Steampunk Wizards’ plan is to further commercialize the Bungee Mummy IP through the launch of subsequent worlds in the adventure puzzler game, and also launch a casual game, consisting of 4 mini games, in the same theme.

Steampunk Wizards has been signed by Steel Media as a preferred partner. Steel Media will be distributing news and product highlights from Steampunk Wizards to its highly targeted audience. Steel Media owns many of the leading mobile gaming websites worldwide, directly representing greater than 85 websites across its portfolio. Through its websites, Steel Media communicates with 45 million avid gamers monthly.

Steampunk Wizards, Inc. (SPWZ), closed Tuesday's trading session at $0.39, up 2.63%, on 28,985 volume with 17 trades. The average volume for the last 60 days is 83,863 and the stock's 52-week low/high is $0.30/$2.12.

DigiPath Corp. (DIGP)

Cannabis Financial Network News, SmallCapVoice, and SECFilings.com News reported on DigiPath Corp. (DIGP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

DigiPath Corp. is a digital pathology solution provider that is rapidly expanding into cannabis testing and related services. The National Marijuana News (TNMNews) is its unbiased cannabis news site and talk radio show. It centers on the political, economic, medicinal, and cultural dimensions of the medicinal and recreational marijuana industry. DigiPath Labs is the cannabis testing subsidiary of the Company. DigiPath has its corporate headquarters in Las Vegas, Nevada.

DigiPath develops and markets accurate and affordable human and animal digital pathology solutions. It is expanding into the botanical, nutraceutical, and cannabis industries with industry-leading testing, education, and training services. The Company’s systems enable entities to create, store, manage, analyze, and correlate data collected via virtual microscopy.  

DigiPath’s line of advanced digital pathology and advisory solutions include marketing, product development, sales, outreach, operations, customer service, regulatory, and financial management services for the healthcare industry. Its DigiPath Labs™ is working to set the industry standard for testing all types of cannabis-based products using Food and Drug Administration (FDA)-compliant laboratory equipment and processes to ensure product and patient safety and effectiveness.

DigiPath has a digital pathology portfolio. PathScope™ is its whole slide imaging system. PathScope™ delivers high-quality real-time images and integrates smoothly with third-party software. PathLive™ is its telepathology system. It delivers high-quality images in real time. PathReview™ is its proprietary web viewer and image server management system for whole digital slide images.

PathConsult™ is DigiPath’s end-to-end digital pathology solution. PathConsult™ enables remote consultation and second opinions, strong reporting and workflow management for histotechnicians, pathologists and administrators. DigiPath’s digital pathology solutions include PathCloud™, PathTrade™, PathStore™, and PathGuarentee™.

DigiPath's accomplishments in 2015 included opening its first state-of-the-art cannabis testing lab, DigiPath Labs, in Las Vegas, Nevada, and testing 250 cannabis flower samples, representing more than 1,250 pounds of cured flower from many of the 16 licensed growers.

Its accomplishments also included performing over 50 interviews of industry leaders and players on The National Marijuana News (TNMNews), and restructuring the business units to focus resources on expanding DigiPath's flourishing medical cannabis testing and media business units, through transferring majority control of Digipath Corp., its business unit focused on digital pathology solutions, to President, Mr. Steven D. Barbee. The Company also named a new Chairman of the Board, Mr. Joe Bianco. He is a business visionary with a background in law and acquisitions. Mr. Bianco will concentrate on replicating the DigiPath Labs model into other cannabis-legal states.

DigiPath Corp. (DIGP), closed Tuesday's trading session at $0.1575, even for the day, on 13,700 volume with 6 trades. The average volume for the last 60 days is 40,091 and the stock's 52-week low/high is $0.10/$0.95.

GenSpera, Inc. (GNSZ)

SmallCapVoice, FeedBlitz, and Standout Stocks reported on GenSpera, Inc. (GNSZ), and today we report on the Company, here at the QualityStocks Daily Newsletter.

GenSpera, Inc. is a biotechnology company whose shares trade on the OTCQB. The Company conceives, designs, and develops cancer therapies. Its technology platform combines a robust, plant-derived cytotoxin (thapsigargin) with a patented prodrug delivery system, which targets the release of drugs within solid tumors without the side effects of chemotherapeutic agents. The Company’s Scientific Advisory Board consists of top researchers who are the inventors of the technology and shareholders.  GenSpera has its headquarters in San Antonio, Texas.

GenSpera’s technology platform supports the development of a group of drugs targeted at different cancers, and also other applications such as imaging. Its lead drug candidate is mipsagargin. It was granted Orphan Drug designation by the US Food and Drug Administration (FDA) in 2013 for evaluation in patients with hepatocellular carcinoma (liver cancer). Phase II clinical trials for lead compound mipsagargin, also known as G-202, are taking place in two indications. One is the aforementioned liver cancer and the other is glioblastoma, or brain cancer.

GenSpera announced in January 2015 the encouraging results of a Phase II study of mipsagargin (G-202), an investigational agent for the treatment of hepatocellular carcinoma (HCC). Mipsagargin targets the enzyme prostate-specific membrane antigen (PSMA) that is highly expressed in tumor vasculature and prostate cancer cells. The Phase II results demonstrated that mipsagargin appears to be effective and is well-tolerated by HCC patients. The Phase II study results (n=25) demonstrate that the prodrug effectively stabilizes progression of HCC by decreasing blood flow within tumors while not affecting blood flow within normal tissues.

GenSpera announced in May 2015 the successful completion of the first stage of an ongoing Phase II study of its lead investigational agent, mipsagargin (G-202), in glioblastoma (brain cancer) and the continuation of enrollment for an expansion phase of the trial. The two-stage, single-arm, open-label study (NCT02067156) is led by David Piccioni, M.D., Ph.D. and Santosh Kesari, M.D., Ph.D. at the UC San Diego Moores Cancer Center in La Jolla, California. The study will evaluate the efficacy, safety, and central nervous system (CNS) exposure in patients with recurrent or progressive glioblastoma.

GenSpera’s goals for 2016 include the clinical development of Mipsagargin - the Phase 2 Glioblastoma (Brain Cancer) Study; the Phase 2 Prostate Cancer Study; and the Phase 2a Dose-escalation Hepatocellular Carcinoma (Liver Cancer) Study.

GenSpera, Inc. (GNSZ), closed Tuesday's trading session at $0.16, even for the day, on 20,350 volume with 9 trades. The average volume for the last 60 days is 84,444 and the stock's 52-week low/high is $0.13/$1.07.

Manhattan Scientifics, Inc. (MHTX)

Hawk Associates and SmallCapVoice reported earlier on Manhattan Scientifics, Inc. (MHTX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed Manhattan Scientifics, Inc. centers on the commercialization of disruptive technologies in the nano-medicine space. At present, the Company is developing commercial medical prosthetics applications for its ultra-fine grain metals. Its aim is to commercialize the cancer research work and nano medical applications developed by Senior Scientific, LLC - a unit of the Company. Manhattan Scientifics has offices in New Mexico, New York, and Montreal.

The Company acquired the exclusive commercial rights (manufacturing and marketing) to Mr. Edward R. Flynn's (President and Chief Executive Officer of Senior Scientific, LLC) patents and Intellectual Property (IP) in the developing field of nano medicine. Particularly, Dr. Flynn's work in biomagnetic detection of cancer and other diseases by way of magnetic field sensors.

Manhattan Scientifics has an agreement to collaborate with The University of Texas M.D. Anderson Cancer Center (MDACC) to advance, demonstrate and validate a revolutionary technology developed by Edward R. Flynn, PhD, for the very early detection of cancer. Manhattan Scientifics has delivered its pioneering cancer measurement instrument to MDACC.  

Manhattan Scientifics creates IP portfolios and business cases supporting new technologies. It guides them to relationships with industrial partners who are well-prepared to launch product. As a result, the lab and inventor see the technology enter the market. The industrial partner gets a strong basis for a new product. Manhattan Scientifics profits from building the licensing bridge to industry.
Manhattan Scientifics is now focusing on nanostructured metals technology through wholly-owned subsidiary Metallicum, Inc. In addition, it is focusing on nanoparticle based cancer detection via wholly-owned subsidiary Senior Scientific.  Furthermore, it is working on the start of product trials on its cancer detection product.

The nanostructured metals technology has been revenue producing for some years. The cancer detection technology can detect cancer years earlier. Manhattan Scientifics has expertise in licensing from the national laboratories (the Los Alamos National Laboratory (LANL) and the Sandia National Laboratory (SNL)) and in working with individual inventors. Its technology employs iron oxide nanoparticles and a technique it calls Magnetic Relaxometry to locate and measure cancers with a sensitivity that would provide a diagnosis years’ before other known methods.

Last month, Manhattan Scientifics announced that its Senior Scientific unit renewed its Collaboration Agreement with The University of Texas MD Anderson Cancer Center. This establishes a multi-year program with extended scope. The agreement calls for MD Anderson to participate in a rigorous development program to translate the pre-clinical research to first use in humans. Senior Scientific is developing a platform for the early detection of cancer and other human diseases.

Manhattan Scientifics, Inc. (MHTX), closed Tuesday's trading session at $0.0624, up 4.44%, on 110,820 volume with 6 trades. The average volume for the last 60 days is 141,095 and the stock's 52-week low/high is $0.0401/$0.1175.

Integrated BioPharma, Inc. (INBP)

Zacks, The Stock Psycho, StockMister, OTCPicks, HotShotStocks, Top Gun, and AllPennyStocks reported on Integrated BioPharma, Inc. (INBP), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Founded in 1979, Integrated BioPharma, Inc. engages primarily in the manufacturing, distributing, marketing, and sales of vitamins, nutritional supplements, and herbal products. Its customers are located mainly in the United States, Luxembourg and Canada. Integrated BioPharma was formerly known as Integrated Health Technologies, Inc. The Company is based in Hillside, New Jersey.

Integrated BioPharma develops, manufactures, and distributes, worldwide, more than 130 products. It does so through a number of wholly-owned subsidiaries. Its companies include AgroLabs, Inc., Chem International, IHT Health Products, Inc., Manhattan Drug Company, and Vitamin Factory. Integrated BioPharma operates through three segments. These are Contract Manufacturing, Branded Proprietary Products, and Other Nutraceutical Businesses.

AgroLabs manufactures and markets healthful nutritional products under the Naturally Noni, Naturally Pomegranate, Naturally Aloe, and Naturally Mangosteen brands. AgroLabs also distributes internationally in Canada, Germany, Japan, Korea, Mexico, Taiwan and the United Kingdom (UK). Integrated BioPharma’s Chem International offers a wide assortment of Roche Vitamins' food and cosmetic products.

Integrated BioPharma’s IHT Health Products sells and distributes fine chemicals. These include science-based proprietary products and value added formulations. It sells and distributes these to the nutritional, pharmaceutical, food, and cosmetic industries. 

IHT products include vitamins, amino acids, herbal extracts, Over-the-Counter (OTC) pharmaceuticals, excipients, and also unique patented products. IHT Health Products has established strategic marketing alliances with different research based companies that have developed patented products unique to the industry.

In addition, Integrated BioPharma’s Vitamin Factory sells nutritional supplements directly to the consumer through mail order catalogs and over the Internet. Its product categories are dietary supplements, liquid items, sports supplements, and skincare supplements.

Furthermore, the Company’s Manhattan Drug Company provides vitamins and nutritional formulations. It engages in the manufacturing of tablets, capsules, or blends; packaging and labeling in bulk; help in product registration worldwide, and distribution of finished product. Manhattan Drug additionally engages in analytical and microbiological testing through its in-house laboratories.

Integrated BioPharma, Inc. (INBP), closed Tuesday's trading session at $0.11, even for the day, on 2,006 volume with 2 trades. The average volume for the last 60 days is 7,431 and the stock's 52-week low/high is $0.072/$0.121.


The QualityStocks
Company Corner


FlexWeek (FXWK)

The QualityStocks Daily Newsletter would like to spotlight FlexWeek (FXWK). Today, FlexWeek closed trading at $1.10, up 4.76%, on 200 volume with 2 trades. The stock’s average daily volume over the past 60 days is 160, and its 52-week low/high is $0.075/$1.15.

FlexWeek, Inc. is a pioneer in the global peer-to-peer (P2P) marketplace with the introduction of a unique platform that allows timeshare owners to discover, book and offer unused vacation time directly to the public and other timeshare owners. This approach eliminates the need for timeshare owners to use costly trading platforms such as Interval International or RCI, while potentially reducing unused timeshare inventory.

FlexWeek (FXWK) is a pioneer in the global peer-to-peer (P2P) marketplace with the introduction of a unique platform that allows timeshare owners to discover, book and offer unused vacation time directly to the public and other timeshare owners. This approach eliminates the need for timeshare owners to use costly trading platforms such as Interval International or RCI, while potentially reducing unused timeshare inventory.

FlexWeek's P2P website (www.FlexWeek.com) and mobile application is similar to AirBNB's $20 billion approach to the travel industry, but is the first and only P2P marketplace exclusive to fractional vacation ownerships. FlexWeek differs from the existing model, where timeshare weeks must be "banked" with a trading company such as Interval International or RCI, and instead charges the booking fees to the renter of the vacation time, eliminating the cost to the private timeshare owner.

The FlexWeek platform also addresses another specific industry challenge. The average timeshare is only booked 79% of the year, according to the American Resort Development Association's 2012 research survey. Whether or not a privately owned timeshare unit is used, the owner still has to pay annual maintenance fees, and most owners end up losing thousands of dollars in wasted paid-for vacation time over their ownership period. With FlexWeek, an owner of unused paid vacation time can now offer their specific booked week for rent directly to the FlexWeek marketplace to recoup cost or even make a profit on the rental. The glut of unused timeshare inventory allows a potential renter to stay in a very nice condo for a fraction of what they would pay in hotel fees making it a win-win for both the owner and the renter of the vacation time.

Led by founder Kristopher Chavez, who has more than 10 years of experience operating businesses that acquire, rent, sell and transfer timeshares internationally, FlexWeek's management team will leverage its collective expertise to facilitate the company's direction and growth in this new market. FlexWeek's leadership has founded rapidly growing sales organizations generating 8-figure revenues within a year's time, and has experience scaling other models to financial success and/or acquisition rapidly with limited investment. Disclaimer

FlexWeek Company Blog

FlexWeek News:

FlexWeek, Inc. (FXWK) is “One to Watch”

FLEXWEEK INC Financials EDGAR Online (Sat, Dec 19)

Agora Holdings, Inc. (AGHI)

The QualityStocks Daily Newsletter would like to spotlight Agora Holdings, Inc. (AGHI). Today, Agora Holdings, Inc. closed trading at $0.13, up 30.00%, on 1,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 44,330, and its 52-week low/high is $0.03/$2.50.

Agora Holdings, Inc. today announced that it has engaged the Corporate Communications Services of QualityStocks. Based in Scottsdale, Arizona, QualityStocks has assisted more than 300 public companies with their efforts to broaden influence, attract growth capital and improve shareholder value over the past 10 years.

Agora Holdings, Inc. (AGHI), together with its wholly-owned subsidiary, Geegle Media, is leading a diversified family entertainment and media enterprise through business segments which include: TV on Demand, interactive media, business products and consumer platforms. With its multi-dimensional approach, Geegle Media supports Agora Holdings' mission to deliver innovate and high-quality business solution products and to deliver video content from around the world.

Geegle Media web platforms include; GeegleTV, Frame, 1000Salads, RealtyTV and LobbyTV. Geegle TV is a multi-platform video entertainment website that curates high-quality video content from around the world. In 2016, GeegleTV will serve as co-producer by airing original content. By exposing undiscovered content to millions of users and rendering it shareable to social media, Geegle TV will serve as a marketing partner to local and internationally based TV shows not yet on the open market.

For commercial use, Geegle Media provides a variety of solutions that include web development and billing software for VoIP applications. RealtyTV is its state-of-the-art platform for real estate brokerages. LobbyTV is another of its widely used products by business offices. For individuals, Geegle TV combines radio, On Demand movies, news, sports and children's content.

Geegle Media is also developing 1000salads, an online hub that encourages healthy lifestyles. The portal will feature recipes and products, health-oriented articles and a curated selection of local restaurants and grocers that deliver to the health-conscious user. Currently in its alpha stage of development, 1000salads is gearing up its sales and marketing in preparation for its launch in 2016.

Geegle Media differs from other On Demand providers, such as Netflix and HBO, in that its service is free of constraints such as subscription, fees and penalties. As consumers increasingly opt for personalized sources of entertainment, Agora recognizes the vast opportunities and growth potential provided by the rising popularity of TV On Demand. The company also benefits from strong and visionary management with a track record of bringing innovative ideas to fruition. Disclaimer

Agora Holdings, Inc. Company Blog

Agora Holdings, Inc. News:

Agora Holdings, Inc. (AGHI) Announces Engagement of QualityStocks Corporate Communications Suite

Agora Holdings, Inc.'s Geegle Media Develops TECH, a Workflow Management Software

Agora Holdings Inc.'s Geegle TV Devising Monetizing Plan for Its Real TV Project

Legacy Ventures International, Inc. (LGYV)

The QualityStocks Daily Newsletter would like to spotlight Legacy Ventures International, Inc. (LGYV). Today, Legacy Ventures International, Inc. closed trading at $1.00, up 1.01%, on 81,461 volume with 50 trades. The stock’s average daily volume over the past 60 days is 36,510, and its 52-week low/high is $0.01/$2.50.

Legacy Ventures International, Inc. is pleased to announce that it has closed an equity private placement comprised of 92,000 shares of common stock at a price of $1.25 per share for total proceeds of $115,000. The securities were sold to accredited investors without registration and cannot be resold without appropriate registration or exemption there from. The proceeds are to be used for general corporate working capital. No commissions or broker fees were paid thereon.

Legacy Ventures International, Inc. (LGYV) is an investment company seeking out high-potential businesses with big ideas that can be scaled in order to promote hyper growth. The company fuels innovation and passion by providing the capital, oversight and connections that young businesses need to reach their full potential.

Legacy is led by a highly-qualified executive team with decades of relevant industry experience. Evan Clifford, the company's chief executive officer, has spent more than 15 years building and maintaining relationships with some of North America's most influential executives. Over the past decade, he has served as a lead advisor to a collection of companies and individuals striving for personal and professional success. Likewise, Rehan Saeed, Legacy's chief financial officer, has over a decade of experience in the banking industry during which he built and managed a real estate portfolio valued at $110 million.

The company's current brand portfolio is headlined by newly-acquired RM Fresh Brands, a servicer of food and beverage retailers and distributors around the globe. RM Fresh Brands takes a unique approach to brand partnerships by maintaining a clear focus on sustainable, category-changing consumables. This strategy has helped it build an extensive portfolio of highly-desirable brands – including Boxed Water, Aloe Gloe, Uncle Si's Iced Tea and Chef 5-Minute Meals.

Following the successful acquisition of RM Fresh Brands, Legacy is in a strong strategic position to move forward with its efforts to promote sustainable growth. The company will lean on the considerable experience of its management team as it looks to build on its recent progress while promoting maximized shareholder value. Disclaimer

Legacy Ventures International, Inc. Company Blog

Legacy Ventures International, Inc. News:

Legacy Ventures Closes Funding

Legacy Ventures Welcomes G. Scott Paterson to the Advisory Committee

Legacy Ventures International Due Diligence Report: Being Green is in; Boxed Water a Step Closer to Reducing the Carbon Footprint

Moxian, Inc. (MOXC)

The QualityStocks Daily Newsletter would like to spotlight Moxian, Inc. (MOXC). Today, Moxian, Inc. closed trading at $4.60, off by 8.00%, on 4,710 volume with 33 trades. The stock’s average daily volume over the past 60 days is 896, and its 52-week low/high is $4.50/$6.50.

Moxian, Inc. a provider of innovative social marketing and promotion platforms for businesses and consumers in China, was recently reviewed in a research report conducted by Crystal Equity Research in New York, New York.

To view the report in its entirety visit http://crystalequityresearch.com/wp-content/uploads/2016/01/MOXC-Update-1-11-16.pdf

Moxian, Inc. (MOXC) engages in the business of providing social marketing and promotion platforms designed to help merchants accelerate and advertise their business growth through social media. These products and services enable merchants to run targeted advertising campaigns and promotions, and aim to enhance the interaction between users and merchant clients by using consumer behavior data compiled from the Moxian database of user activities. The company has two primary core products: Moxian+ User App and Moxian+ Business App.

Developed in Shenzhen, China, Moxian integrates social media, entertainment and business intelligence. The Multi-Channel Social Commerce Platform, which includes a variety of tools such as Moxian's proprietary Social Customer Relationship Management (SCRM) system, generates knowledgeable data for merchants. This way, consumers and businesses are able to connect and interact with one another to achieve the concept of "online lifestyle, offline fun."

Moxian+ User App serves as an App driven for consumer users to use the platform, consisting of our proprietary virtual currency (MO-Coin and MO-Points), social networking, redemption centre and game centre. Users can earn MO-Coins by playing games, and then use those coins to redeem prizes sponsored by Moxian and client merchants. This model not only drives registered consumers to Moxian and merchant, but also provides merchants the opportunity to advertise, run marketing campaigns, and learn about their customers through the Platform.

Moxian+ Business App is an independent App with built in Social Customer Relationship Management tool built for merchants. Merchants are able to set up a store on the Moxian platform through this business App, push promotions via a variety of methods offered on the platform and look at generated report customized to their own shop.

Moxian's management team has more than 100 years of combined experience in a variety of pertinent endeavors, including management of private and public enterprise, multi-national organizations, quality, engineering and procurement, finance, marketing, communication and more. Together, Moxian's management team is effecting the company's aim to create and lead a personalized social network platform that best fits users and businesses. Disclaimer

Moxian, Inc. Company Blog

Moxian, Inc. News:

Moxian, Inc. Covered by Crystal Equity Research

Moxian, Inc. Establishes Beijing Subsidiary, Defines Expansion Plans

MissionIR Exclusive Audio Interview With Moxian, Inc. (MOXC) Creative & Marketing VP Edmund Ooi

Oakridge Global Energy Solutions, Inc. (OGES)

The QualityStocks Daily Newsletter would like to spotlight Oakridge Global Energy Solutions, Inc. (OGES). Today, On the Move Systems, Inc. closed trading at $0.657, up 19.45%, on 14,034 with 8 trades. The stock’s average daily volume over the past 60 days is 21,548, and its 52-week low/high is $0.20/$2.40.

Oakridge Global Energy Solutions, Inc. (OGES) is an integrated energy storage solutions company focused on the design, development and manufacture of high-quality cells, batteries and power systems. The company's innovative 'Made in the U.S.A.' product line includes multiple lithium-ion technologies and form factors that are optimized to address three high-demand target markets – including stationary and grid storage; motive applications, such as electric and hybrid electric fleet vehicles; and specialty applications, such as military, aerospace, marine, medical and telecom backup.

Through a recent restructuring of its operations, Oakridge strategically positioned itself to expand its market reach moving forward. The company currently owns and operates two manufacturing facilities in Melbourne, Florida, which play an instrumental role in its efforts to meet the growing demand for its cutting-edge large format Pro Series golf car batteries and its small format Patriot Series RC batteries. These operations also allow Oakridge to bring stable employment opportunities back to the U.S., effectively highlighting its tireless commitment to the revitalization of the country's manufacturing industry.

The company also maintains a presence on the international stage through its recently formed subsidiary, Oakridge Global Energy Solutions Limited, Hong Kong. This subsidiary, which is expected to serve as the foundation for Oakridge's sales efforts throughout the Asia-Pacific region, was created primarily to address the tremendous international demand for its revolutionary stored energy solutions. The company also maintains a substantial interest in Leclanche S.A., a Swiss developer and manufacturer of large-sized lithium-ion batteries that was originally founded in 1909.

Oakridge has indicated plans to expand its presence in a collection of markets throughout Europe and Asia as it continues to build upon its established product development and manufacturing infrastructure. The company will lean on the expertise of its proven management team – which includes well over a century of combined industry experience – as it looks to increase its share of the $12 billion domestic battery manufacturing industry. Disclaimer

Oakridge Global Energy Solutions, Inc. Company Blog

Oakridge Global Energy Solutions, Inc. News:

Oakridge Announces New Corporate Image, Branding and Media Communications Tools as it Enters Full-Scale Production for 2016

Oakridge Providing Batteries for Unmanned Maritime Vessels

Oakridge Sells Interest in Leclanche S.A., Releasing Funding for Corporate Growth

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $2.76, off by 4.83%, on 11,978 volume with 40 trades. The stock’s average daily volume over the past 60 days is 17,538, and its 52-week low/high is $1.25/$11.625.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.

The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.

In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Signed a Clinical Service Agreement With the Florey Institute of Neuroscience and Mental Health

International Stem Cell Corporation Receives Authorization to Initiate Phase I/IIa Clinical Trial of ISC-hpNSC for the Treatment of Parkinson's Disease

International Stem Cell Corporation Announces Launch Plans for New Nano-Compound Products


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Daily Trade Alert





By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251